GSK is taking the lead in "bioelectronics", which aims to treat injury and diseases such as...


GSK is taking the lead in "bioelectronics", which aims to treat injury and diseases such as stroke, epilepsy and even diabetes through electrical signalling in the brain and elsewhere in the body. GSK's not yet pumping huge amounts of money into the field, but aims to act as a co-ordinator for the disparate research going on globally.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs